Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 2Breast 1

Conditions

Skin Neoplasms 1Radiodermatitis 1Neoplasms, Squamous Cell 1Melanoma 1Immune System Diseases 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Dimethyl Sulfoxide × Clear all
NCT05932511 2023-08-30

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Center for Biomedical Research, Inc.

Phase EARLY_PHASE1 Unknown
15 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Neoplasms, Squamous Cell

NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed
48 enrolled
Breast

Breast Neoplasms, Radiodermatitis

NCT00118313 2020-03-27

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

University of Virginia

Phase 1 Completed
Dermatologic

Melanoma

NCT02519816 2019-08-14

CARE

Maisonneuve-Rosemont Hospital

Phase 2 Unknown
17 enrolled

Immune System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡